Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS One. 2008 Apr 2;3(4):e1900. doi: 10.1371/journal.pone.0001900.

Appetite enhancement and weight gain by peripheral administration of TrkB agonists in non-human primates.

Author information

1
Rinat, Pfizer Inc., South San Francisco, California, United States of America. john.lin@rinat.pfizer.com

Abstract

Loss of function mutations in the receptor tyrosine kinase TrkB pathway resulted in hyperphagia and morbid obesity in human and rodents. Conversely, peripheral or central stimulation of TrkB by its natural ligands BDNF or NT4 reduced body weight and food intake in mice, supporting the idea that TrkB is a key anorexigenic signal downstream of the melanocortin-4 receptor (Mc4r) system. Here we show that in non-human primates TrkB agonists were anorexigenic when applied centrally, but surprisingly orexigenic, leading to gain in appetite, body weight, fat deposits and serum leptin levels, when given peripherally. The orexigenic and pro-obesity effects of peripherally administered TrkB agonists appear to be dose dependent, not associated with fluid retention nor with evidence of receptor down regulation. Our findings revealed that TrkB signaling exerts dual control on energy homeostasis in the primates that could be targeted for the treatment of either wasting disorders or obesity.

PMID:
18382675
PMCID:
PMC2270901
DOI:
10.1371/journal.pone.0001900
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center